Introduction The 2023 Project CBD report examines the complex interplay between cannabis use and schizophrenia, challenging common misconceptions and offering […]
Introduction In their 2023 article, Project CBD critically explores the complex relationship between cannabis use and schizophrenia. It addresses misconceptions
Introduction In a 2023 study published in Behavioral Pharmacology, Suárez Santiago and colleagues investigated the use of ketamine as a
Introduction Schizophrenia is a challenging mental illness that can cause problems with memory and thinking. Researchers like Dr. Suárez Santiago
None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases. You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.